Correlation between Plasma Macrophage Migration Inhibitory Factor Levels and Long-Term Prognosis in Patients with Acute Myocardial Infarction Complicated with Diabetes
Table 1
Baseline characteristics of the participants.
Characteristics
Diabetes STEMI group ()
Nondiabetes STEMI group ()
Control group ()
Age () (years)
Male, (%)
44 (77.2)
124 (84.4)
51 (78.4)
BMI () (kg/m2)
eGFR () (mL·min-1·kg-1)
Systolic pressure at presentation () (mmHg)
Diastolic pressure at presentation () (mmHg)
Heart rate at presentation () (beats/min)
Onset to visit , (%)
47 (82.5)
112 (76.2)
—
Anterior myocardial infarction, (%)
22 (38.6)
67 (45.6)
—
Killip , (%)
15 (26.3)
19 (12.9)
—
LVEF () (%)
—
Hypertension, (%)
42 (73.7)
62 (42.2)
—
Hyperlipidemia, (%)
19 (33.3)
52 (35.4)
—
Active smoker, (%)
37 (64.9)
106 (72.1)
—
White blood cell count ()
Peak value of CK-MB (U/L)
203 (141-300)
192 (149, 322)
—
Peak value of hs-TnT (ng/mL)
4.0 (2.3-6.3)
4.3 (2.4-6.2)
—
NT-pro-BNP (pg/mL)
1005 (438-2490)
992 (373, 1864)
—
hs-CPR (pg/mL)
6.0 (2.0-15.7)
6.9 (3.0-15.6)
0.9 (0.2-2.7)
LDL-C () (mmol/L)
Random blood glucose (mmol/L)
9.7 (5.8–12.4)
5.5 (4.9–7.1)
—
HbAlc () (%)
—
Data are presented either as , percentage, or median (25th percentile, 75th percentile). Categorical variables are indicated as percentage (%) of patients. compared to the control group; compared to the nondiabetes STEMI group. BMI: body mass index; eGFR: estimated glomerular filtration rate; LVEF: left ventricular ejection fraction; CK-MB: isoenzyme of creatine kinase-muscle/brain; hs-TnT: high-sensitive troponin T; Nt-pro-BNP: N-terminal pro-b-type natriuretic peptide; hs-CPR: hypersensitive C-reactive protein; LDL-C: low-density lipoprotein cholesterol; HbAlc: glycosylated hemoglobin.
